Clostridium difficile toxin A/B inhibitors (MabVax)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameClostridium difficile toxin A/B inhibitors (MabVax)
Drug Alias NameClostridium difficile toxin A/B inhibitors (MabVax)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionToxin B inhibitorsToxin A inhibitors
TargetsToxin AToxin B
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabvax Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A